Penederm Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
A Powerful Buy Signal
Article By: Marc Lichtenfeld
Saturday, September 12, 2020 4:29 PM EDT
Phase 2 trials are my favorite time to get involved in a biotech company. Phase 2 is often the most profitable time to be involved in a small cap biotech stock. Many times, Phase 2 results are positive.
In this article: PFE, CVM, CLDX, REGN, DCTH, MELA, DERM, NVCR
Read
Getting Past China’s Coronavirus
Article By: James Gornick
Thursday, January 30, 2020 10:01 AM EDT
The truest treasures of cures from deaths caused by the regular H1N1 Flu and mutations of MERS, SARS, Ebola, HIV are sometimes, deeply hidden within proof of concept/efficacy of the U.S. Patents held by the biotechnology company.
In this article: INO Also: DERM
Read
Stock Charts To Watch - Wednesday, Jan. 8
Video By: Harry Boxer
Wednesday, January 8, 2020 9:28 PM EDT
Clovis Oncology, Inc. had a big reversal day on Wednesday.
In this video: LSCC, CLVS, SGMS, DERM, COLL, SAVA
Watch
Biotech Digest – CLRB Reports Positive Results, TNDM Receives New Patent, DERM Inks New Deal
Article By: KKD Healthcare Analytics
Wednesday, August 9, 2017 10:13 AM EDT
Cellectar Biosciences stock shot up as the company announced achieving overall survival of 22.5 months to date after a single dose infusion of 12.5mCi/m2 in patients with multiple myeloma.
In this article: AET, AGN, BDX, JNJ, SNY, PLX, ACRX, ANTH, TNDM, AMRN, DERM, AKBA, AVXS, CLRB, ZBH
Read

Latest Tweets for $DERM

No tweets yet!

PARTNER HEADLINES